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Abstract
Backgound: The Scottish Antimicrobial Prescribing Group (SAPG) was established by the Scottish Government in
2008 to lead the first national initiative to actively address antimicrobial stewardship. Healthcare associated
infection (HAI) is a priority in Scotland and the work of SAPG contributes to the national HAI Delivery Plan. SAPG’s
early work has focused on restricting the use of antibiotics associated with a high risk of Clostridium difficile
infection (CDI) and development of national prescribing indicators to support reduction of CDI.
Findings: Scottish Antimicrobial Prescribing Group has developed prescribing indicators for hospital and primary
care, which are measured and reported in all 14 NHS board areas. Improvement in compliance with the indicators
has been demonstrated with resultant reductions in CDI rates and no adverse effect on mortality or antimicrobial
resistance patterns.
Conclusions: The establishment of a Scottish national antimicrobial stewardship programme has made a
significant contribution to the HAI agenda, particularly in relation to CDI. The programme is supported by local
antimicrobial teams, a national framework for education, surveillance of antimicrobial use and resistance and
sharing of data for improvement. Antimicrobial stewardship has been integrated with other national programmes
on patient safety and quality improvement.
Keywords: Antimicrobial stewardship, Clostridium difficile infection, prescribing indicators, quality improvement
Background
The Scottish Antimicrobial Prescribing Group (SAPG)
[1] was formed in March 2008 by the Scottish Govern-
ment Health Department (SGHD) to implement the
recommendations of the Scottish Management of Anti-
microbial Resistance Action Plan (ScotMARAP) [2].
SAPG operates as a multidisciplinary national clinical
forum and its primary objectives are to co-ordinate and
deliver a national framework for antimicrobial steward-
ship to enhance the quality of antimicrobial prescribing
and management in Scotland.
Materials and methods
SAPG was established to lead the first national initiative
to actively address antimicrobial stewardship. Collabora-
tion with key stakeholders at national level and develop-
ment of local (NHS board level) leadership through
Antimicrobial Management Teams has been essential to
develop national consensus and implement key steward-
ship interventions. This has been combined with the
development of national and local systems and a frame-
work for collecting and disseminating data on antibiotic
prescribing and resistance surveillance and a framework
for educational material to support the healthcare pro-
fessionals in the workplace.
Healthcare associated infection (HAI) is a priority for
the Scottish Government and the work of SAPG contri-
butes to the national HAI Delivery Plan. Reduction of
Clostridium difficile infection (CDI) is a key objective
for NHS Scotland and in 2009 a target was set for all
NHS boards to reduce their rate by 30% (later increased
to 50%) in patients over 65 years. Much of the focus of
SAPG’s early work has therefore been to reduce the use
of antibiotics associated with a high risk of CDI across
hospital and primary care settings. SAPG developed
national prescribing indicators based on compliance
with local antibiotic policies to support reduction of
CDI:
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Empirical Prescribing in hospital
Indication for treatment recorded in the patient medical
record and antibiotic choice is compliant with the local
Antimicrobial Prescribing Policy - target ≥ 95%
Primary care prescribing
Seasonal variation in quinolone use, consumption of
quinolones in winter months is ≤ 5% greater than con-
sumption in summer months.
Results
National surveillance data confirm that there has been a
progressive reduction in CDI throughout Scotland and
that all NHS boards have exceeded the original target of
30% reduction. The national rate has fallen from 1.5 to
0.32 cases per 1000 acute occupied bed days [3].
Improvement in the quality of antimicrobial prescribing
in hospital and primary care has made a significant con-
tribution to this reduction.
Changes in antibiotic use
National results for the hospital and primary care CDI
prescribing indicators are shown in Additional file 1,
Table S1 and Additional File 2, Figure S1
Impact on outcomes
Clostridium difficile infection (CDI)
There is a temporal association between this reduction
and the introduction of restrictive antimicrobial policies in
line with SAPG guidance. The true impact of this inter-
vention is being evaluated using a time series analysis and
results from one region (NHS Tayside) show a reduction
in total CDI post-intervention of 54% in Medicine and
50% in Surgery [4]. The attendant cost avoidance due to
this reduction in CDI in is estimated at more than £500 K
per year (based on £4 K per CDI episode [5]).
Unintended consequences
National surveillance of antimicrobial resistance shows
no significant increases in resistance to key Gram-nega-
tive organisms and reduced resistance to third genera-
tion cephalosporins in E. coli. Aminoglycoside-related
toxicity is also being prospectively evaluated.
Mortality
Crude 30-day all-cause mortality (from admission) was
analysed for both NHS Tayside cohorts. No change was
observed following the introduction of the restricted
antibiotic policy. Subgroup analysis by age and Charlson
Co-morbidity Index score showed no changes in mortal-
ity following the introduction of the policy. Further ana-
lysis using adjusted 30-day mortality in patients who
have had blood cultures taken as an outcome indicator
for sepsis management and antibiotic stewardship inter-
ventions is also being undertaken.
Conclusion
The establishment of a Scottish National Antimicrobial
Stewardship Programme has made a significant contri-
bution to the HAI agenda, particularly in relation to
CDI [6]. Providing local clinical prescribing leadership
through Antimicrobial Management Teams and orga-
nisational accountability through agreed national tar-
gets for prescribing have been key success factors in
bringing about this change. This is supported by a
national framework for education, timely sharing of
data using the Institute for Healthcare Improvement
Extranet and a range of local improvement strategies
in collaboration with local infection prevention and
quality improvement teams. Aligning antimicrobial
stewardship with patient safety and quality improve-
ment which are key elements of the national Quality
Strategy [7] has also been particularly helpful. During
the next three years we aim to consolidate our success
and embark upon further collaborative improvement
work in primary care prescribing, surgical prophylaxis
and management of sepsis, the latter being a signifi-
cant cause of hospital mortality and morbidity and a
national priority for 2012.
Additional material
Additional file 1: Table S1 Compliance with empirical prescribing in
Medical Admission Units April - June 2011. Summary of data for
national prescribing indicator for empirical prescribing in hospital.
Additional file 2: Figure S1 Primary care seasonal variation of
quinolone use by NHS board 2008-2011. Annual data for national
prescribing indicator for primary care.
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